Drugs / MEDI3414
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00945893 | Aug → Sep 2009 | — | MedImmune LLC | Completed | Mixed |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00946101 Comparator | Aug → Sep 2009 | influenza | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEDI3414 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00945893 ↗ |
| Modality | Vaccine | “H1N1 monovalent influenza vaccine (MEDI3414)” NCT00945893 ↗ |
| Route | Intranasal | “MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]” NCT00945893 ↗ |